Soluble CD40 ligand in acute coronary syndrome in cocaine users

被引：0
|
作者：
Dominguez-Rodriguez, Alberto [2 ]
Abreu-Gonzalez, Pedro [3 ]
Enjuanes-Grau, Cristina [2 ]
Juarez-Prera, Ruben [2 ]
Arroyo-Ucar, Eduardo [2 ]
Burillo-Putze, Guillermo [1 ]
机构：
[1] Hosp Univ Canarias, Serv Urgencias, Tenerife 38320, Spain
[2] Hosp Univ Canarias, Serv Cardiol, Tenerife 38320, Spain
[3] Univ La Laguna, Dept Fisiol, Tenerife, Spain
来源：
EMERGENCIAS | 2011年 / 23卷 / 02期
关键词：
Cocaine; Inflammation; Unstable angina; Atherosclerosis; EMERGENCY-DEPARTMENT; INFLAMMATION; RISK;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Background and objectives: The soluble CD40 ligand (sCD40L) expressed on platelets is released in the activation process. We analyzed the sCD40L serum concentration in cocaine users with acute coronary syndrome (ACS). Patients and methods: Retrospective comparison of sCD40L serum concentration between 40 patients with ACS and a positive test for cocaine in urine and 40 ACS patients with a negative cocaine test. Results: The mean (SD) sCD40L serum concentration in the patients with ACS and a negative cocaine test was lower (110 [41.1] pg/mL) than in patients who were not cocaine users (65.3 pg/mL) (P=.03). In the multivariable analysis, after adjustment for age and coronary risk in these patients with ACS, a positive cocaine test remained associated with sCD40L concentration. Conclusions: The sCD40L plays a part in the proinflammatory thrombotic process in cocaine users who develop ACS. [Emergencias 2011;23:104-107].
引用
收藏
页码：104 / 107
页数：4
相关论文
共 50 条
  • [1] Prognostic utility of the soluble CD40 ligand in acute coronary syndrome
    Lindberg, Soren
    CORONARY ARTERY DISEASE, 2014, 25 (07) : 548 - 549
  • [2] Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation
    Dominguez-Rodriguez, Alberto
    Abreu-Gonzalez, Pedro
    Garcia-Gonzalez, Martin J.
    Kaski, Juan Carlos
    THROMBOSIS RESEARCH, 2009, 123 (04) : 617 - 621
  • [3] Soluble CD40 ligand in acute coronary syndromes
    Heeschen, C
    Dimmeler, S
    Hamm, CW
    van den Brand, MJ
    Boersma, E
    Zeiher, AM
    Simoons, ML
    CAPTURE Study Investigators
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12): : 1104 - 1111
  • [4] Soluble CD40 ligand in acute coronary syndromes
    Kritharides, L
    Lau, GT
    Freedman, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25): : 2575 - 2575
  • [5] Soluble CD40 ligand in acute coronary syndromes - Reply
    Heeschen, C
    Hamm, CW
    Zeiher, AM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25): : 2576 - 2577
  • [6] Soluble CD40 ligand is associated with angiographic severity of coronary artery disease in patients with acute coronary syndrome
    Zhao Wei
    Zhang Fan
    Li Zijian
    Yu Haiyi
    Li Zongshi
    Gao Wei
    CHINESE MEDICAL JOURNAL, 2014, 127 (12) : 2218 - 2221
  • [7] Soluble CD40 ligand is associated with angiographic severity of coronary artery disease in patients with acute coronary syndrome
    Zhao Wei
    Zhang Fan
    Li Zijian
    Yu Haiyi
    Li Zongshi
    Gao Wei
    中华医学杂志（英文版）, 2014, (12) : 2218 - 2221
  • [8] Soluble CD40 ligand and CD40 ligand/platelet ratio are predictors of ventricular function and adverse clinical outcome among acute coronary syndrome patients
    Gharini, P. P. R.
    Hartopo, A. B.
    Setianto, B. Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 551 - 551
  • [9] Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome
    Budi Y. Setianto
    Anggoro B. Hartopo
    Putrika P. R. Gharini
    Dyah W. Anggrahini
    Bambang Irawan
    Heart and Vessels, 2010, 25 : 282 - 287
  • [10] Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome
    Setianto, Budi Y.
    Hartopo, Anggoro B.
    Gharini, Putrika P. R.
    Anggrahini, Dyah W.
    Irawan, Bambang
    HEART AND VESSELS, 2010, 25 (04) : 282 - 287
12345